AusCann Group Holdings Ltd.

AusCann Group Holdings Ltd.

AusCann Group Holdings Ltd.

Overview
Date Founded

2014

Headquarters

85 Carabooda Road,Carabooda, Western Australia (WA) 6033

Type of Company

Public

Industries

Pharmaceuticals
Beverages

Company Description

AusCann Group Holdings Ltd. engages in the provision of medical development. It involves in the production of cannabis medicine for numerous application including anti-convulsion, neuroprotectant, anti-inflammatory, anti-nausea, glaucoma, pain management, and appetite simulation. The company was founded on September 2014 and is headquartered in neuroprotectant, anti-inflammatory, anti-nausea, glaucoma, pain management. The company was founded in September 2014, and is headquartered in Carabooda, Australia.

In The News
Australian Financial Review
January 6, 2018
AusCann 'light years' ahead of medical cannabis rivals
Australian Financial Review
December 27, 2017
MEDICINAL CANNABIS: THE NEW GOLD RUSH
The Globe and Mail (Canada)
September 14, 2017
CANOPY SIGNS EXCLUSIVE DEAL WITH AUSTRALIAN CANNABIS DISTRIBUTOR
News Bites Canadian Markets
September 14, 2017
Canopy Growth Provides Further International Updates
Subscribe now to see full news coverage
Executives & Employees

Managing Director

Secretary

Subscribe now to see full list of current and former executives
Board of Directors

Chairman at AusCann Group Holdings Ltd.

Councilor at The Association of Mining & Exploration Cos., Inc.

Co-Founder at Canopy Growth Corp.

Special Advisor at BioScience Managers Pty Ltd

Subscribe now to see full list of current and former board members
Paths to AusCann Group Holdings Ltd.
Potential Connections via
Relationship Science
You
AusCann Group Holdings Ltd.
Key Stats and Financials As of 2017
Market Capitalization
$437M
Total Enterprise Value
$638M
Earnings Per Share
$-0.01
Revenue
$0
Net Profit
$-14.1M
EBITDA
$-6.83M
Total Debt
$0
Total Equity
$15M
TEVNet Income
-45.1x
Debt TEV
0x
Three Year Compounded Annual Growth Rate Of Revenue
0%
Five Year Compounded Annual Growth Rate Of Revenue
0%
Subscribe now to see full financial details